Intech Biopharm Corporation (6461.TWO)
TWD 18.15
(-0.55%)
TWD 18.15
(-0.55%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.71 Billion TWD | 6.3% |
| 2022 | 2.55 Billion TWD | -1.97% |
| 2021 | 2.6 Billion TWD | -0.76% |
| 2020 | 2.62 Billion TWD | 0.61% |
| 2019 | 2.6 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.55 Billion TWD | -6.03% |
| 2024 Q1 | 2.72 Billion TWD | 0.38% |
| 2023 Q3 | 2.42 Billion TWD | -2.13% |
| 2023 Q2 | 2.47 Billion TWD | -2.39% |
| 2023 FY | 2.71 Billion TWD | 6.3% |
| 2023 Q1 | 2.53 Billion TWD | 0.0% |
| 2023 Q4 | 2.71 Billion TWD | 11.89% |
| 2022 FY | 2.55 Billion TWD | -1.97% |
| 2022 Q4 | - TWD | 0.0% |
| 2021 FY | 2.6 Billion TWD | -0.76% |
| 2020 FY | 2.62 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 6.544% |
| Level Biotechnology Inc. | 822.67 Million TWD | -229.544% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -307.849% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -394.046% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 30.377% |
| GlycoNex Incorporation | 1.55 Billion TWD | -74.591% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -130.505% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -262.166% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -616.528% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -139.104% |
| Visgeneer Inc. | 397.17 Million TWD | -582.586% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 28.096% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -25.569% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -206.996% |
| Neith Corporation | 192.15 Million TWD | -1310.89% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 55.503% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -3585.62% |
| Enimmune corporation | 604.82 Million TWD | -348.239% |
| TaiRx, Inc. | 833.74 Million TWD | -225.167% |
| EirGenix Inc. | 11.16 Billion TWD | 75.713% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -373.021% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -58.323% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 24.624% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -158.079% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -800.591% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -924.37% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -514.489% |
| RBC Bioscience Corporation | 753.79 Million TWD | -259.658% |
| BiOptic Inc. | 613.77 Million TWD | -341.705% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -52.421% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -133.77% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -320.419% |
| VBI | 452.1 Million TWD | -499.658% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 12.15% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2017.244% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 12.722% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1732.62% |
| NaviFUS Corp. | 490.53 Million TWD | -452.676% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -121.182% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -98.85% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -412.348% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -133.434% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -63.684% |
| AP Biosciences Inc | 890.75 Million TWD | -204.356% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 68.207% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -736.367% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -103.283% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 82.354% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -560.82% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -583.145% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -30.596% |
| TCI GENE Inc. | 1.16 Billion TWD | -132.522% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -820.313% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -98.856% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -187.872% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -288.154% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 31.433% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 29.079% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -120.441% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 51.622% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -155.278% |
| Acepodia, Inc. | 6.81 Billion TWD | 60.24% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 29.15% |